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Background: The tumorous infiltration or carcinosis of the pericardium could cause pericardial effusion in up to
one-third of cases of malignancy, thus potentially interfere with the otherwise desirable oncological treatment. The
existing surgical methods for the management of pericardial fluid are well-established but are not without
limitations in the symptomatic relief of malignant pericardial effusion (MPE). The recurrence rate ranges between 43
and 69% after pericardiocentesis and 9 to 16% after pericardial drainage. The desire to overcome relative limitations
of the existing methods led us to explore an alternative approach.
Methods: The standard armamentarium of the Carlens collar mediastinoscopy procedure was utilized in a
Chamberlain parasternal approach of the pericardial sac. The laterality of approach was decided based upon the
pleural involvement, as tumor-free pericardiopleural reflection is required. A pericardio-pleural window at least 3 cm
in diameter was created. From January 2000 to December 2009, 22 cases were operated on with mediastinoscope-
controlled parasternal fenestration (MCPF). Considering the type of the primary tumor, there were 11 lung cancer, 6
breast cancers, 2 haematologic malignancies and in 3 patients the origin of malignancy could not be verified.
Results: There were no operative deaths. We lost one patient (4.5%) in the postoperative hospital period. All of the
surviving patients had a minimum of 2 months of symptom-free survival. We detected transient recurrence of MPE
in one patient (4.5%) 14 days after the MCPF, which disappeared spontaneously after 24 hours.
Conclusion: The MCPF offers a real alternative in certain cases of pericardial effusion. We recommend this method
especially for the definitive surgical palliation of MPE.
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The number of patients with secondary malignant peri-
cardial effusion is steadily increasing due to the improv-
ing efficacy of complex cancer treatment modalities.
Metastases to the myocardium have reportedly been
found in up to 1.23% of all autopsies [1]. The incidence
of malignancy associated with pericardial involvement
ranges from 8 to 20% in other autopsy studies [2-4]. The
tumorous infiltration or carcinosis of the pericardium
could cause pericardial effusion in up to one-third of
cases of malignancy, thus potentially interfere with the
otherwise desirable oncological treatment [4].* Correspondence: szucs.geza@upcmail.hu
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reproduction in any medium, provided the orThe existing surgical methods for the management of
pericardial fluid are well-established but are not without
limitations in providing symptomatic relief of malignant
pericardial effusion. Pericardiocentesis and the Larrey-
Fontenelle approaches [5,6] using a subxyphoideal fenes-
tration have a recurrence rate ranging between 43 and
69% after pericardiocentesis [3,7] and 9 and 16% after
pericardial drainage [8-11]. The video-assisted thoraco-
scopic surgical (VATS) pericardio-pleural fenestration is
highly efficient but requires anaesthesia with contralat-
eral single-lung ventilation which is compromising in
patients with an already reduced cardio-pulmonary re-
serve [8,12,13]. The transdiaphragmatic pericardial fen-
estration was developed as an alternative method, but
the pericardio-peritoneal window might be blocked by
the adjacent abdominal structures and is a two-cavityd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 The place of pericardial window (left side).
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limitations detailed above led us to explore an alternative
approach.
Having extensive experience in collar mediastinoscopy,
we utilized the existing armamentarium of the Carlens
procedure [16] in a Chamberlain approach in order to
achieve pericardial decompression in the form of a peri-
cardiopleural window [17-19].
Methods
The patient was placed in a 10–30 degree supine Fowler
position. Anaesthesia was introduced with single lumen
endotracheal tube. A transverse skin incision was made
above the sternal end of the third or fourth rib, a little
bit longer than the expected length of its cartilaginous
part. The laterality of approach (i.e. left or right) was
decided based upon the pleural involvement, as tumor-
free pericardiopleural reflection is required. In the case
of synchronous pleural carcinosis the opposite side was
our choice. A left-sided approach was preferred when
both pleural cavities were suitable for the procedure.
After blind splitting the pectoral muscles the sternal
edge of the rib was resected. The internal thoracic artery
and vein were identified and secured in order to avoid
annoying bleeding in the course of later manipulation.
The pleural cavity was opened close to its mediastinal
reflection. A limited exploration of the thoracic cavity
was undertaken introducing a rigid mediastinoscope
(Karl Storz GMBH, Tuttlingen, Germany), and biopsies
were performed if suspicious parenchyma/pleural lesions
were present (Figure 1). Keeping aside the lung with a
long retractor a holding stitch secured pericardial access
ventrally to the phrenic nerve. Lifting up this stitch, a
window an at least 3 cm in diameter was created on the
pericardium using scissors to manipulate within or par-
allel to the main tube of the mediastinscope (Figure 2,
3). The effluent pericardial liquid was emptied with mildFigure 1 The position of patient and the place of incision of
left side mediastinoscope-controlled parasternal pericardial
fenestration.suction and a 20 Ch marked silicone chest tube was
inserted into the pleural cavity. The chest tube was kept
under suction (50–100 mbar) for 48 to 72 hours and
was removed following chest X-ray control. Bacterial
and cytological examination of the pericardial fluid and
the histological examination of the pericardium speci-
men completed the procedure. The pain in the first
postoperative days was alleviated with parenteral Trama-
dol and Diclofenac administration.
From January 2000 to December 2009, 22 cases out of
the 73 consecutive patients with pericardial fluid that we
treated were operated on with the mediastinoscope-
controlled parasternal pericardial fenestration (MCPF)
described above. 12 female and 10 male with average age
of 57 years (min. 26, max. 72, SD 11) underwent MCPF.
Almost all the MCPF cases were operated on by two of
the six surgeons in the department. So, in the first part
of the examined period the patient selection for MCPF
depended primarily on the surgeon. In the second half
of the examined period, we preferred to perform MCPF
in cases of MPE if the patient had no severe symptoms
of pericardium tamponade. If so we were compelled to
perform percutaneous pericardiocentesis or subxyphoi-
deal fenestration. In non-malignant cases also the subxy-
phoideal fenestration is preferred. The methods other
than MCPF that we applied and the number of patients
are summarized in Table 1.
The average procedure time of MCPF was 31 minutes
(min. 20, max. 50, SD 9,5) and the average hospital stay
Figure 3 The intrapleural situation after parasternal pericardial fenestration (right side).
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type of the primary tumor, there were 11 lung cancer, 6
breast, no gastrointestinal, 2 haematologic malignancies.
In 3 cases out of 22 parasternally fenestrated patients, a
malignant origin was not verified.
For statistical analysis we used the “Statistica 9.0” soft-
ware package (Stat Soft Inc. USA). The mean values and
the standard deviation (SD) were calculated for age, op-
eration time, hospital stay and survival. The confidence
interval was 95%. The Kaplan-Meier survival curve was
made also with the Statistica 9.0 software package. The
result was controlled with the “Matlab R2010b” software
package (MathWorks Inc. USA). This calculation also
shows the lower and upper confidence bounds for the
cumulative distribution of survival (Figure 4). These
bounds were calculated using Greenwood’s formula. In
the cases of those two patients who were still alive at the
end of the examined period, the survival times were used
in the calculation and are shown in the curve as cen-
sored data. The comparison of survivals was analyzed
with Student’s two-sample t-test. The critical value of “t”
was given at a level of 95% (significance level: p< 0.05)
with n1 + n2-2 degrees of freedom and was comparedTable 1 Different surgical methods for solving pericardial
effusion in the examined period
Percutaneous pericardiocentesis + drain 23
Subxyphoideal fenestration 23
Mediastinoscopy-controlled parasternal fenestration 22
Transdiaphragnatic pericardio-peritoneal fenestration 2
VATS pericardio-pleural fenestration 2
Thoracotomy, pericardio-pleural fenestration 1
Total 73with the calculated “t” value. The statistical analyses
were calculated with an assumed normal distribution.
Due to the low number of patients, the result is only of
informative value and would require an even larger test
sample.Results
There were no operative deaths in the group of 22
MCPF patients. Transient intraoperative dysrhythmia
was detected in 3 cases (14%). We lost one patient
(4.5%) in the postoperative hospital stay. This end-stage
cachectic lung-cancer patient died due to a cascade ofFigure 4 The cumulative distribution of patients survival, and
the lower and upper confidence bounds of cumulative
distribution of survival after parasternal pericardial
fenestration.
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was 9.4 days (SD 1.3).
The postoperative pain was easily relievable in spite of
the small partial subperiosteal parasternal rib resection.
Usually after two to four days our patients did not re-
quire additional continuous therapy with painkillers be-
cause of postoperative pain. Our patients recovered
without difficulty – considering their original complaints
and physical incapacity caused by their malignant
disease.
Due to the low number and the heterogeneity of the
reported 22 MCPF patients regarding their origin of pri-
mary malignancy and performance status, the long-
term survival rate could be only of informative value
(Figure 4). The follow-ups and the oncologic treatment
were done in different hospitals and not by us. We hadTable 2 The demography, primary malignancy, operative tim
operated with MCPF
No Age Sex Primary malignancy Op time (min.
1 51 m pulmonary 20
2 53 m pulmonary 20
3 68 f pulmonary 30
4 53 f breast 35
5 50 f ? 50
6 46 f breast 25
7 47 m pulmonary 40
8 72 f ? 40
9 50 f breast 40
10 47 m pulmonary 25
11 65 m pulmonary 35
12 71 f hematologic 50
13 57 f breast 40
14 54 m ? 20
15 26 m pulmonary 20
16 60 m pulmonary 40
17 73 f breast 20
18 59 m pulmonary 30
19 67 f pulmonary 30
20 61 f breast 25
21 68 f hematologic 30







*Statistically significant difference, p< 0.05.correct information regarding survival for our MCPF
patients in 14 cases of 22. All of the surviving patients
had a minimum of 2 months of symptom-free survival.
The detailed data of our MCPF patients can be seen in
Table 2.
We detected transient recurrence of the pericardial
fluid in one patient (4.5%) 14 days after the MCPF. The
echocardiography revision after 24 hours did not detect
an echolucent zone around the heart, and the recidive
pericardial effusion disappeared spontaneously.Discussion
The demand for a definitive palliative treatment of neo-
plastic pericardial effusion led us to develop an alterna-
tive method of pericardial fenestration.e, hospital stay and the survival of the 22 patients
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lish the methodology of mediastinoscope-controlled
parasternal fenestration of the pericardium (MCPF) that
we have developed and applied. The pericardio-pleural
fenestration with parasternal approach is an easy to per-
form, straightforward procedure. It is easy demonstrable,
trainee-friendly, and does not require sophisticated man-
ual skill. It requires no special tools. Single-lung ventila-
tion is not necessary in the course of the operation. This
strictly palliative method is minimally invasive, cost effi-
cient, and provides immediate relief from complaints
and symptoms caused by the pericardial effusion. The
pericardial fluid produced empties into the pleural cavity
across the pericardio-pleural window and will be
absorbed on the bigger pleural surface. In our 10 year
series of operations with 22 patients there was no pro-
longed recurrence of pericardial effusion, so the MCPF
fulfilled what we had expected with a low hospital mor-
tality rate.
Unfortunately, the idea presented is not exclusively
new. A method not significantly different from ours was
first described by Calvin in 1971. He suggested the para-
sternal mediastinotomy as a possible clinical application
for pericardial fenestration [20]. We have found one art-
icle of a case report using the same approach for solving
the problem of tension pneumo-pericardium [21] and
another about pericardioscopy performed with the same
armamentarium [22]. However our Pub Med search was
unable to reveal any publication that discussed an appli-
cation of parasternal pericardial fenestration in cases of
neoplastic pericardial effusion.
Conclusions
The existing methods for solving the clinical conse-
quences of pericardial fluid are well-known and safely
performed. We do not offer our method instead of
them!
However the malignant pericardial effusion and its
relatively high recurrence rate is a special problem. The
MCPF is a possible choice in such special cases. The
mortality was low and the recurrence rate tended to zero
in our patients treated with MCPF. Single-lung ventila-
tion was not necessary in the course of the operation.
The postoperative care and the mobilization of our
patients were without difficulty and the postoperative
pain was easily relievable in spite of the small partial
subperiosteal parasternal rib resection. In our everyday
practice we definitely prefer MCPF in cases of MPE to
VATS or subxyphoideal fenestration.
On the other hand we do not think it a mistake to per-
form MCPF in non-malignant cases, but considering its
advantages we recommend this “new-old method” espe-
cially for the definitive surgical palliation of pericardial
effusion with malignant origin.Abbreviations
Ch: Charriere, 0,33 mm; MCPF: Mediastinoscope-controlled parasternal
pericardial fenestration; MPE: Malignant pericardial effusion; SD: Standard
deviation; VATS: Video-assisted thoracoscopic surgery.
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